Skip to main content

Five-minute Q & A: Data & analytics for planning

Computer with graphs and analytics displayed. Notepad and phone sit next to computer.

New trends and change agents are increasingly challenging health systems’ volume and revenue growth. To compete and stay relevant, they must take a more balanced approach to their near-, mid-and long-term growth.

DataGen and Sg2 recently joined forces to host Optimizing strategic planning for revenue growth: DataGen and Sg2 resources. This webinar featured customers' experiences using Sg2's suite of analytical tools and how, when partnered with DataGen's customized customer service and training, these tools helped their organization optimize its strategic planning for enhanced revenue growth. 

We broke down five common questions asked during the session.

1.       What disruptors are you keeping an eye on? 

  • We are keeping an eye on four major disruptors: Retail clinics, big tech/digital, VC-backed medical groups and payers as providers. 

2.       What downstream effects have these disruptors had on inpatient volumes? 

  • Nationally, IP utilization has remained well below pre-pandemic levels through Q2 2022. Through Sg2’s partnership with Strata Decision Technology, we compared adult quarterly volumes from 2019 vs. 2020-2022. Across the country, there is a decline of 10% when you include COVID-19 diagnosis and 14% when you exclude COVID-19 diagnosis. 

3.       What downstream effects have these disruptors had on outpatient volumes? 

  • Outpatient volume demonstrates recovery and growth beyond pre-pandemic levels. According to Strata Decision Technology, the adult quarterly volumes, including COVID-19 from 2019 vs. 2020-2022, revealed OP, OP surgery and E&M are all up between 4% and 5%, while ED visits are flat.  

4.       What are some key 2022 forecast considerations? 

  • Endemic COVID-19 
  • Rising patient acuity  
  • Shift to OP slowing 
  • Expanded care at home capabilities 
  • Record MA enrollment 

5.       What does today’s winning growth portfolio look like? 

  • Near-term: Drive an optimal patient mix through the existing footprint. 
  • Mid-term: Increase revenue and margin capture for patients you serve. 
  • Long-term: Evolve and expand the footprint to win more patients. 
Struggling to get a comprehensive view of your market, competitive position and growth opportunities to guide your strategic planning? Check out how DataGen's partnership with Sg2 can help.


Popular posts from this blog

Unlock the Potential of Value-based Payment

A common misconception in healthcare practices: Organizations can quickly reap the benefits of value-based payment transformation. To launch a successful value-based payment program , practices must implement a variety of foundational pieces. It may take time, resources and data before a practice can successfully engage in VBP. In this blog, we'll cover what goes into VBP and its potential benefits. We'll also dig deeper into practice advancement strategies and how they can help you achieve your practice goals. What goes into VBP? Many practices want to implement VBP because of its payment structure and return on investment. Yet, they might not consider how to nurture a successful VBP program in their organization. It starts with a gap analysis regarding people, processes and technologies. It’s important to celebrate what is working well and intervene where improvement can be made. Successful VBP starts with the practice team. There are many perceptions vs. realities that exist

BPCIA: 4 fast facts for a successful Model Year 7 kickoff

Participation in Model Year 7 launched on Jan. 1, 2024, with the first few months being a critical time for providers. New Bundled Payments for Care Improvement Advanced Model (BPCIA) participants got their footing, and continuing participants were able to change their clinical episode service line groups for the first time since 2020.  If you’re a provider participating in this model, read on for a BPCIA refresher and four fast facts for starting MY7 right. We’ll also cover core analytics activities to support your clinical and operational success.   4 Fast facts on BPCIA Model Year 7  1.   Focus on clinical episodes and episode volume  Before MY7 began, providers used historic baseline data provided by CMS to evaluate which CESLGs they would go at risk for, ensuring there would be sufficient episode volume. Large episode volume (100 episodes/year or more) reduces random variation and helps protect providers from financial risk associated with outlier Medicare episode spend.    During